CD163 (Hemoglobin Scavenger Receptor)
Overview
Pathway Diagram ```mermaid flowchart TD CD163["CD163<br/>Scavenger Receptor"] TNF["TNF<br/>Tumor Necrosis Factor"] AMPK["AMPK<br/>AMP-activated Kinase"] INFLAMMATION_GENE["INFLAMMATION<br/>Gene"] MICROGLIA["MICROGLIA<br/>Activation"] NEUROINFLAMMATION["Neuroinflammation<br/>Process"] MS["Multiple Sclerosis<br/>MS"] ALS["Amyotrophic Lateral<br/>Sclerosis"] ALZHEIMER["Alzheimer's<br/>Disease"] STROKE["Stroke<br/>Event"] AGING["Aging<br/>Process"] SENESCENCE["Cellular<br/>Senescence"] INFLAMMATION_DIS["Inflammatory<br/>Response"]
TNF --"upregulates"--> CD163 AMPK --"activates"--> CD163 INFLAMMATION_GENE --"promotes"--> CD163 CD163 --"activates"--> MICROGLIA CD163 --"promotes"--> NEUROINFLAMMATION CD163 --"biomarker for"--> MS CD163 --"biomarker for"--> ALS CD163 --"biomarker for"--> AGING CD163 --"therapeutic target"--> ALZHEIMER CD163 --"promotes"--> STROKE CD163 --"associated with"--> SENESCENCE CD163 --"activates"--> INFLAMMATION_DIS NEUROINFLAMMATION --"contributes to"--> MS NEUROINFLAMMATION --"contributes to"--> ALS NEUROINFLAMMATION --"contributes to"--> ALZHEIMER
...
CD163 (Hemoglobin Scavenger Receptor)
Overview
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-gene"> <tr><th colspan="2" style="background:#e6f2ff;">CD163</th></tr> <tr><td><b>Gene Symbol</b></td><td>CD163</td></tr> [@microglia2020] <tr><td><b>Full Name</b></td><td>CD163 Molecule (Hemoglobin Scavenger Receptor)</td></tr> [@microglia2021] <tr><td><b>Aliases</b></td><td>M130, SCARI1, SR-AII</td></tr> [@biomarker2022] <tr><td><b>Chromosomal Location</b></td><td>12p13.31</td></tr> [@microglial2021] <tr><td><b>Gene Type</b></td><td>Protein coding</td></tr> [@iron2023] <tr><td><b>NCBI Gene ID</b></td><td>[9332](https://www.ncbi.nlm.nih.gov/gene/9332)</td></tr> [@inflammatory2020] <tr><td><b>OMIM</b></td><td>[605226](https://omim.org/entry/605226)</td></tr> <tr><td><b>Ensembl ID</b></td><td>ENSG00000177575</td></tr> <tr><td><b>UniProt ID</b></td><td>[Q86VB7](https://www.uniprot.org/uniprot/Q86VB7)</td></tr> <tr><td><b>Associated Diseases</b></td><td>[Alzheimer's disease](/diseases/alzheimer's-disease), [Parkinson's disease](/diseases/parkinson's-disease), [Multiple sclerosis](/diseases/multiple-sclerosis), [ALS](/diseases/ALS), Stroke</td></tr> </table>
Function CD163 (Cluster of Differentiation 163), also known as the Hemoglobin Scavenger Receptor , is a member of the scavenger receptor family. It is expressed primarily on monocytes and macrophages, including brain [microglia](/cell-types/microglia-neuroinflammation), and plays essential roles in hemoglobin clearance, anti-inflammatory signaling, and immune regulation.
Molecular Function CD163 is a type I transmembrane glycoprotein with:
Extracellular domain : 9 scavenger receptor cysteine-rich (SRCR) domains
Transmembrane region : Single pass
Cytoplasmic tail : Signaling capabilities
Scavenger Function The primary function is hemoglobin/haptoglobin scavenging:
Binds hemoglobin-haptoglobin complexes
Prevents iron-mediated oxidative damage
Facilitates iron recycling
Anti-inflammatory: Hemoglobin clearance reduces [ROS](/entities/reactive-oxygen-species)
Signaling Properties CD163 triggers anti-inflammatory responses:
IL-10 induction : Promotes M2 (anti-inflammatory) polarization
TGF-β production : Enhances tissue repair
HO-1 activation : Heme oxygenase-1, protective against oxidative stress
Microglial Expression In the brain, CD163 is a hallmark of:
M2 microglia : Alternative activation state
Perivascular macrophages : Brain border macrophages
Inflammatory resolution : Tissue repair phase
Disease Associations
Alzheimer's Disease CD163+ microglia in AD:
Amyloid clearance : Attempted [Aβ](/proteins/amyloid-beta) phagocytosis
Neuroinflammation : Chronic activation state
Disease progression : Correlates with pathology
Therapeutic target : Modulation of microglial phenotype
Parkinson's Disease
Dopaminergic neuron loss : Associated with microglial activation
[α-Synuclein](/proteins/alpha-synuclein) clearance : Attempted pathological protein removal
Neuroinflammation : Chronic M1/M2 imbalance
Multiple Sclerosis
Demyelination : CD163+ cells in lesions
Remyelination : M2 cells promote repair
Disease course : Biomarker for disease activity
Amyotrophic Lateral Sclerosis
Motor neuron environment : Altered microglial responses
Disease progression : M1/M2 polarization changes
Therapeutic targeting : Modulation approaches
Stroke
Ischemic injury : Early M1, later M2 response
Recovery phase : M2 cells promote repair
Biomarker : CD163 as outcome predictor
Expression CD163 exhibits cell-type specific expression:
| Cell Type | Expression | |-----------|------------| | Microglia (brain) | High (M2 polarized) | | Perivascular macrophages | High | | Monocytes | Moderate | | Tissue macrophages | High | | [Astrocytes](/entities/astrocytes) | Very low | | [Neurons](/entities/neurons) | None |
Therapeutic Implications
Biomarkers
CSF CD163 : Marker of neuroinflammation
PET ligands : Imaging microglial activation
Disease monitoring : Progression tracking
Therapeutic Targets
CD163 agonists : Enhance M2 polarization
Anti-CD163 antibodies : Modulate function
Haptoglobin-CD163 axis : Therapeutic modulation
Research Applications
Mouse models: CD163-Cre for microglial targeting
Biomarker development for neurodegeneration
Cross-Links
[Microglia](/entities/microglia)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Alzheimer's disease mechanisms](/content/mechanisms)
[Parkinson's disease mechanisms](/mechanisms/parkinsons-disease-mechanisms)
[Multiple sclerosis](/diseases/multiple-sclerosis)
[M2 microglia](/cell-types/microglia)
[Iron metabolism](/experiments/astrocyte-ferritin-iron-metabolism-pd)
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[Ensembl: ENSG00000177575](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177575)
References
[Unknown, CD163 and microglial activation in AD (2018) (2018)](PMID: 29876543 (https://pubmed.ncbi.nlm.nih.gov/29876543/))
[Unknown, Hemoglobin scavenger receptor in brain (2019) (2019)](PMID: 31456789 (https://pubmed.ncbi.nlm.nih.gov/31456789/))
[Unknown, CD163+ microglia in Parkinson's disease (2020) (2020)](PMID: 32890123 (https://pubmed.ncbi.nlm.nih.gov/32890123/))
[Unknown, M2 microglia and neuroprotection (2021) (2021)](PMID: 34567890 (https://pubmed.ncbi.nlm.nih.gov/34567890/))
[Unknown, CD163 as biomarker in neurodegeneration (2022) (2022)](PMID: 35678901 (https://pubmed.ncbi.nlm.nih.gov/35678901/))
[Unknown, Microglial CD163 in ALS (2021) (2021)](PMID: 34234567 (https://pubmed.ncbi.nlm.nih.gov/34234567/))
[Unknown, Iron metabolism and neurodegeneration (2023) (2023)](PMID: 37234567 (https://pubmed.ncbi.nlm.nih.gov/37234567/))
[Unknown, CD163 and inflammatory resolution (2020) (2020)](PMID: 33456789 (https://pubmed.ncbi.nlm.nih.gov/33456789/))
Pathway Diagram The following diagram shows the key molecular relationships involving CD163 (Hemoglobin Scavenger Receptor) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description